Admescope Ltd is a privately owned contract research organisation (CRO) providing the pharmaceutical, biotechnology and veterinary industry with premium quality tailor-made services to drug discovery and development in the area of ADME-Tox. Our unique expertise lies in drug metabolism, drug interactions, pharmacokinetics and quantitative bioanalysis, where we stand out with our innovative approach combined with the latest technology.
The team consists of chemists, biochemists, pharmacologists and technicians, all with long experience and strong expertise in ADME-studies. Admescope serves customers in 28 different countries on four continents, having planned and conducted a high number of ADME-related studies for biotech and big pharma companies. In addition to our HQ and primary research site in Oulu, we have a research site in Södertälje, Sweden.
Consultancy services for health industry, Health & Life Science, Life Science, pharmaceutical, Other